Target intelligence / Profile preview

Bromodomain adjacent to zinc finger domain protein 1A (BAZ1A)

Target
BAZ1A
Molecular classification
Chromatin remodeler, Epigenetic modulator, Reader domain protein, Other
01

Overview

Bromodomain adjacent to zinc finger domain protein 1A (BAZ1A) is a regulatory subunit of the ATP-dependent chromatin assembly factor (ACF) and chromatin accessibility complex (CHRAC), both members of the imitation switch (ISWI) family of chromatin remodeling complexes[1][2][6]. BAZ1A contains a plant homeodomain (PHD) zinc finger, a bromodomain, a WAC motif, and a leucine-rich helical motif[1][2]. It functions as an epigenetic reader and is involved in the dynamic assembly and spacing of nucleosomes, thereby enabling chromatin to be remodeled in processes like DNA replication, gene transcription, and DNA repair[1][2][6]. BAZ1A directly cooperates with the ATPase SMARCA5, plays a critical role in various DNA repair pathways (nucleotide excision repair, non-homologous end joining, homologous recombination), and regulates gene expression, partly through transcriptional suppression of genes such as those under control of the vitamin D receptor[1][3][5]. Variants in BAZ1A are linked to neurodevelopmental disorders, including intellectual disability, and may affect pathways such as vitamin D metabolism and Wnt signaling[3][5][6]. BAZ1A is considered a potential drug target in epigenetics but, as of now, there are no small molecule drugs specifically targeting BAZ1A clinically reported[1].

Other names
ACF1WCRF180HSPC317hACF1WALp1Williams syndrome transcription factor-related chromatin-remodeling factor 180ATP-dependent chromatin remodeling proteinATP-utilizing chromatin assembly and remodeling factor 1CHRAC subunit ACF1hWALp1
02

Mechanism of action

Epigenetic regulation via chromatin remodeling; Reader of epigenetic marks (acetyl-lysine)

03

Biological functions

Chromatin remodelingDNA repairGene expression regulationNeurodevelopmentDNA replicationTranscriptional suppressionOther
04

Disease associations

Neurodevelopmental disorderIntellectual disabilityAutism spectrum disorderEpilepsyOther
05

Safety considerations

Essential for neurodevelopment—functional disruption implicated in intellectual disability and epilepsyPotential effects on global chromatin accessibility risk off-target gene regulation in therapy

Beyond the preview

Go deeper on Bromodomain adjacent to zinc finger domain protein 1A (BAZ1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bromodomain adjacent to zinc finger domain protein 1A (BAZ1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call